Board changes at Benitec, Ventracor, BioDiem
Thursday, 17 February, 2005
The management changes at RNAi player Benitec (ASX:BLT) continued yesterday, with the announcement that company secretary Gary Taylor had resigned as a director of the company. Taylor will remain company secretary.
Ventracor (ASX:VCR) has appointed medical devices executive Peter Crosby as chief operating officer. Crosby -- an Australian who has served as CEO of four international medical device companies -- will take on the marketing, sales and distribution of Ventracor's VentAssist device.
BioDiem (ASX:BDM) has appointed former Deutsche Bank executive Andrew O'Brien to its board as a non-executive director. O'Brien headed the Australian healthcare corporate finance at Deutsche Bank, and currently works for consulting firm BioIncyte.
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
